Vitamin K affects the prognosis of the COVID-19, California plum demand surges
Previously, Dutch scientists found that reasonable supplementation of vitamin K can improve the prognosis of COVID-19. California plum industry is busy coping with the surge in demand for dried plums.
Prunes contain vitamin K and a range of other vitamins, minerals, and fiber to support overall health and immune system health.
A Dutch study published in the journal "Preprints" showed that vitamin K content affects the breakdown of tissue fibers (including elastin), which are associated with lung diseases. Vitamin K plays a role in producing proteins that regulate blood clotting. Researchers encourage reasonable intake of vitamin K, except for the use of blood clotting drugs.
Represented by the California Plum Association (CPB), this year's plum growers and packagers ushered in increased demand. CPB said that compared with 2019, California’s exports of prunes to the United Kingdom increased by 10%, exports to Germany’s prunes increased by 7%, and the Polish market increased by a substantial 87%. Japanese consumers also started to hoard goods, and exports increased by 14%.
As new research further points out the importance of vitamin K, the California plum industry is expected to further increase global exports.
Beijing outbreak dampens oil demand
2026-07-27
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
This Week's Isopropyl Alcohol Market Prices Slightly Increased (9.1-9.5) in China
-
Pfizer's paxlovid reduces the risk of COVID-19 by 26%
-
The battle between Pfizer and Gilead over COVID-19 drugs will continue
-
1200 cases were newly prescribed by Junshi Biologic for mild to moderate disease
-
Twenty-five COVID-19 Vaccines In China Enter Stages Of Clinical Trials
-
Pfizer to Increase Production Capacity of COVID-19 Oral Drugs, Invest 120 Million US Dollars
-
Anke Bio and Afana Collaborate on mRNA Vaccines for Mutant Strains Such as COVID-19 Omicron
-
As Low as $25/session! Pfizer's COVID-19 Oral Drug Paxlovid Generic Drug Price Released
-
Survey On Corona Deaths By Country
-
COVID-19 Drug Remdesivir Approved for Infants And Young Children
Recommend Reading
-
WACKER Launches Next-Gen Polysilicon Line in Germany 50 Percent Capacity Boost Targets Semiconductor Demand
-
2026 Q1 Chemical Giant Earnings: Supply Contraction, Flat Demand, Full-Scale "Defense Priority"
-
Torrent Pharma Targets First Wave Semaglutide Launch Revenue Up 11 Percent as Patent Ends
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
November Benzene Market Overview (November 1-28, 2025) in China
-
Phosphate Market Prices Rise in the First Half of April (April 1–April 15)
-
In November, the caustic soda price generally declined in China
-
Multiple Positive Factors Drive Significant Increase in MTBE Market in China
-
Both Supply and Demand Weak, ABS Market Prices Continue to Decline in the First Half of June